

1,401,972 filings since 2004 · latest accepted Nov 4, 2026, 6:48 AM ET
Priority items usually mark a change in credit, accounting integrity, control or listing status: 1.02 Agreement terminated, 1.03 Bankruptcy, 1.05 Cybersecurity incident, 2.04 Debt acceleration, 2.05 Restructuring costs, 2.06 Impairment, 3.01 Delisting notice, 4.01 Auditor change, 4.02 Non-reliance (restatement), 5.01 Change in control.
| Filed | Company | Items | Filing |
|---|---|---|---|
Nov 2, 2026 accepted 9:51 AM ET | ABVCABVC BIOPHARMA, INC. | 1.01Material agreement1.02Agreement terminated2.03New debt obligation3.02Unregistered equity sale5.07Shareholder vote7.01Reg FD disclosure | Document |
Source: SEC EDGAR. Same-day filings appear within minutes and are re-checked against SEC's nightly index. Tickers are current listings, so a company's older filings show its ticker today.
Jul 2, 2026 accepted 4:01 PM ET | ABVCABVC BIOPHARMA, INC. | 4.01Auditor change | DocumentSEC ↗ |
Mar 3, 2026 accepted 4:14 PM ET | ABVCABVC BIOPHARMA, INC. | 2.02Earnings release4.02Non-reliance (restatement) | DocumentSEC ↗ |
Sep 12, 2025 accepted 7:16 PM ET | ABVCABVC BIOPHARMA, INC. | 8-K/A 4.01Auditor change | DocumentSEC ↗ |
May 14, 2025 accepted 8:30 AM ET | ABVCABVC BIOPHARMA, INC. | 8-K/A 3.01Delisting notice7.01Reg FD disclosure | DocumentSEC ↗ |
May 6, 2025 accepted 4:30 PM ET | ABVCABVC BIOPHARMA, INC. | 8-K/A 3.01Delisting notice | DocumentSEC ↗ |
May 2, 2025 accepted 4:30 PM ET | ABVCABVC BIOPHARMA, INC. | 8-K/A 4.02Non-reliance (restatement) | DocumentSEC ↗ |
Apr 30, 2025 accepted 4:30 PM ET | ABVCABVC BIOPHARMA, INC. | 3.01Delisting notice3.02Unregistered equity sale | DocumentSEC ↗ |
Apr 15, 2025 accepted 4:30 PM ET | ABVCABVC BIOPHARMA, INC. | 2.02Earnings release4.02Non-reliance (restatement)7.01Reg FD disclosure | DocumentSEC ↗ |
Jan 13, 2025 accepted 6:56 PM ET | ABVCABVC BIOPHARMA, INC. | 8-K/A 3.01Delisting notice7.01Reg FD disclosure | DocumentSEC ↗ |
Oct 18, 2024 accepted 5:23 PM ET | ABVCABVC BIOPHARMA, INC. | 4.01Auditor change | DocumentSEC ↗ |
Jul 12, 2024 accepted 4:05 PM ET | ABVCABVC BIOPHARMA, INC. | 3.01Delisting notice | DocumentSEC ↗ |
May 17, 2024 accepted 5:00 PM ET | ABVCABVC BIOPHARMA, INC. | 8-K/A 1.01Material agreement1.02Agreement terminated | DocumentSEC ↗ |
Aug 31, 2023 accepted 8:30 AM ET | ABVCABVC BIOPHARMA, INC. | 3.01Delisting notice | DocumentSEC ↗ |
Aug 9, 2023 accepted 5:00 PM ET | ABVCABVC BIOPHARMA, INC. | 8-K/A 3.01Delisting notice | DocumentSEC ↗ |
Jul 14, 2023 accepted 5:00 PM ET | ABVCABVC BIOPHARMA, INC. | 8-K/A 3.01Delisting notice | DocumentSEC ↗ |
May 26, 2023 accepted 4:31 PM ET | ABVCABVC BIOPHARMA, INC. | 3.01Delisting notice | DocumentSEC ↗ |
Feb 16, 2023 accepted 4:30 PM ET | ABVCABVC BIOPHARMA, INC. | 3.01Delisting notice | DocumentSEC ↗ |
Oct 21, 2022 accepted 4:30 PM ET | ABVCABVC BIOPHARMA, INC. | 4.01Auditor change | DocumentSEC ↗ |
Aug 22, 2022 accepted 4:30 PM ET | ABVCABVC BIOPHARMA, INC. | 3.01Delisting notice | DocumentSEC ↗ |